Published: Mar 11, 2021 By Alex Keown
Saniona, a rare disease-focused company based in Sweden, received feedback from the U.S. Food and Drug Administration (FDA) on a path forward for its hypothalamic obesity (HO) drug Tesomet. Based on guidance from the regulatory agency, Saniona is planning a Phase IIb study in this indication in the first half of this year.
“There is currently no medicine approved for hypothalamic obesity, a rare disease secondary to hypothalamic injury, characterized by intractable weight gain and complicated by uncontrollable hunger,” Rudolf Baumgartner, Chief Medical Officer and Head of Clinical Development at Saniona said in a statement. “We are encouraged by this feedback from the FDA and look forward to continuing a constructive dialogue with them as we prepare to initiate our Phase IIb clinical trial with Tesomet.”
Scientists at Riga Technical University have discovered new methods to acquire purine compounds that could be used in medicine and technology, Latvian Television reported March 11.
Karachi: Former students of the University of Karachi (KU)-based in the Washington DC and Baltimore area of the USA have donated a system to energise two of the key faculties of the university by solar power.
Sindh Law and Environment Minister Barrister Murtaza Wahab inaugurated the 32.5 kilowatts grid-tied solar system installed on the KU campus to energise its Arts and Social Sciences faculties. The Washington DC and Baltimore chapter of Karachi University Alumni Association donated the renewable energy system comprising of 74 solar panels having cost around Rs 3.05 million. The system will help KU save 150 units of electricity daily.
Earlier, the same alumni association donated the solar system for the Department of Applied Chemistry and Chemical Technology of the KU.
Ein Computer-Modell erklärt das Dendritenwachstum in Lithium-Akkus faz.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from faz.net Daily Mail and Mail on Sunday newspapers.